期刊文献+

环肺静脉消融术对心房颤动患者生活质量的影响 被引量:3

Effects of circumferential pulmonary vein ablation on life quality of patients with atrial fibrillation
暂未订购
导出
摘要 目的:评价环肺静脉消融术(CPVA)对心房颤动患者生活质量的影响。方法:应用SF-36量表对56例接受CPVA的心房颤动患者,分别于入院时和消融后6个月进行生活质量评价。结果:随访(13±4)个月,43例(77%)患者维持窦性心律。6个月后SF-36量表中除肌体疼痛差异无统计学意义外,躯体功能、躯体角色、总体健康状况、活力、社会功能、精神角色和精神健康均较消融前有明显改善(P<0.05)。总躯体健康评分从(68±15)分提高至(76±15)分(P<0.01),总精神健康评分从(63±16)分提高至(73±17)分(P<0.01)。结论:CPVA能明显改善心房颤动患者的生活质量,尤其在消融成功者中,CPVA可使患者生活质量明显改善。 Objective: To evaluate the effects of circumferential pulmonary vein ablation(CPVA) on quality of life(QOL) of patients with atrial fibrillation(AF).Methods: QOL of 56 patients with AF received CPVI and evaluated by Short Form-36(SF-36)at baseline and 6-month after CPVI.Results: After a mean follow-up of 13±4 months,43 patients were free from AF without anti-arrhythmic drugs.There were significant improvements in QOL(except for body pain) after CPVA.The physical component summary scores(PCS) of SF-36 were 68±15 and 76±15 before and after treatment,respectively,with significant improvement(P〈0.01),while the mental component summary scores(MCS) were 63±16 and 73±17,respectively,with significant improvement(P〈0.01).Conclusion:QOL of patients with AF can be improved after CPVA in particular in patients free from AF after treatment.
出处 《新医学》 2012年第1期7-9,共3页 Journal of New Medicine
关键词 心房颤动 环肺静脉消融术 生活质量 躯体健康 精神健康 Atrial fibrillation Circumferential pulmonary vein ablation Quality of life Physical fitness Mental fitness
  • 相关文献

参考文献8

  • 1康德英,王家良,洪旗.健康相关生存质量量表在心血管疾病研究中的常用分析评价方法[J].中国临床康复,2002,6(15):2192-2195. 被引量:16
  • 2李鲁,王红妹,沈毅.SF-36健康调查量表中文版的研制及其性能测试[J].中华预防医学杂志,2002,36(2):109-113. 被引量:2553
  • 3PAPPONE C, ROSANIO S, AUGELLO G, et al. Mortal- ity, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study [ J ]. J Am Coil Cardiol, 2003, 42 (2) : 185-197.
  • 4WOKHLU A, MONAHAN K H, HODGE D O, et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect[J]. J Am Coll Cardiol, 2010, 55 (21): 2308- 2316.
  • 5JENKINS L S, BRODSKY M, SCHRON E, et al. Quali- ty of life in atrial fibrillation: the Atrial Fibrillation Fol- low-up Investigation of Rhythm Management (AFFIRM) study[J]. Am Heart J, 2005, 149 (1) : 112-120.
  • 6VAN GELDER I C, HAGENS V E, BOSKER H A, et al. A comparison of rate control and rhythm control in pa- tients with recurrent persistent atrial fibrillation [ J ]. N Engl J Med, 2002, 347 (23) : 1834-1840.
  • 7CARLSSON J, MIKETIC S, WINDELER J, et al. Ran- domized trial of rate-control versus rhythm-control in per- sistent atrial fibrillation : the Strategies of Treatment of At- rial Fibrillation (STAF) study [ J ]. J Am Coil Cardiol, 2003, 41 (10): 1690-1696.
  • 8ROY D, TALAJIC M, NATTEL S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure [J]. N Engl J ned, 2008, 358 (25): 2667-2677.

二级参考文献22

  • 1陈和年,方积乾.生存质量研究[J].中华预防医学杂志,1993,27(3):178-180. 被引量:36
  • 2万崇华,方积乾.生存质量资料的统计分析方法[J].中华预防医学杂志,1996,30(3):172-174. 被引量:41
  • 3Ware JE Jr, Snow KK, Kosinski M, et al.SF-36 health survey manual and interpretation guide.Boston: New England Medical Center the Health Institute,1993.1-12.
  • 4Perneger TV, Leplege A, Etter JF,et al.Validation of a French-language version of the MOS 36-Item Short Form Health Survey(SF-36) in young healthy adults.J Clin Epidemiol, 1995,48:1051-1060.
  • 5Guillemin F, Bombardier C, Beaton D.Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.J Clin Epidemiol, 1993,46:1417-1432.
  • 6Gandek B, Ware JE Jr.Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach.International Quality of Life Assessment.J Clin Epidemiol, 1998,51:953-959.
  • 7顾杏元,金丕焕.直线回归与相关.见: 金丕焕,主编.医用统计方法.上海:上海医科大学出版社,1993.115-119.
  • 8Lam CL, Gandek B, Ren XS, et al.Tests of scaling assumptions and construct validity of the Chinese(HK) version of the SF-36 Health Survey.J Clin Epidemiol, 1998,51:1139-1147.
  • 9Ren XS, Amick B 3rd, Zhou L, et al.Translation and psychometric evaluation of a Chinese version of the SF-36 Health Survey in the United States.J Clin Epidemiol, 1998,51:1129-1138.
  • 10Till JE, Osoba D, Pater JL, et al.Research on health-related quality of life: dissemination into practical applications.Qual Life Res, 1994,3:279-283.

共引文献2566

同被引文献25

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1408
  • 2常际平,马桂霞.药物复律治疗阵发性房颤并心衰疗效观察[J].中国误诊学杂志,2007,7(11):2493-2494. 被引量:2
  • 3Fuster V, Ryd6n LE, Cannom DS, et al. ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiol- ogy Committee for Practice Guidelines (Writing Commit- tee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) . Circulation, 2006, 114: e257-e354.
  • 4Van Gelder IC, Groenveld HF, Crijns HJ, et al. Leni- ent versus strict rate control in patients with atrial fibril- lation. N Engl J Med, 2010, 362: 1363-1373.
  • 5European Heart Rhythm Association, European Associ- ation for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) . Europace, 2010, 12: 1360-1420.
  • 6Wann LS, Curtis AB, January CT, et al. 2011 ACCF! AHA/HRS focused update on the management of pa- tients with atrial fibrillation (Updating the 2006 Guide- line) : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 123: 104- 123.
  • 7Authors/Task Force Members, Camm ALl, Lip GY, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the Euro- pean Heart Rhythm Association. Eur Heart J, 2012, 24.
  • 8Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events ( ACTIVE W) : a random- ised controlled trial. Lancet. 2006. 367, 1903-1912.
  • 9Connolly SJ, Pogue J, Hart RG, et al. Effect of clopi- dogrel added to aspirin in patients with atrial fibrillation. N Engl J Med, 2009, 360: 2066-2078.
  • 10Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med, 2009, 361: 1139-1151.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部